MEDI-9253

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMEDI-9253

Drug Alias NameN/A

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionInterleukin-12 stimulants

TargetsInterleukin-12

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesFrance

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A